American Medical Systems Gives Notice of Make-Whole Fundamental Change Conversion Rights to Holders of 4.00% Convertible Senior Subordinated Notes Due 2041

American Medical Systems Holdings, Inc. AMMD announced that, pursuant to the terms of the indenture governing its 4.00% Convertible Senior Subordinated Notes due 2041, a “Make-Whole Fundamental Change” occurred on June 17, 2011 as a result of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 10, 2011 among Endo Pharmaceuticals Holdings Inc., NIKA Merger Sub, Inc., a wholly owned indirect subsidiary of Endo, and AMS. As previously disclosed, under the Merger Agreement, Endo acquired AMS for $30.00 per share of common stock, par value $0.01 per share of AMS. Merger Sub merged with and into AMS on June 17, 2011, with AMS continuing as the surviving corporation and a wholly owned subsidiary of Endo. Completion of the Merger constitutes a Make-Whole Fundamental Change under the 2041 Indenture.